CN1188414A - 用于肽释放的新型组合物 - Google Patents
用于肽释放的新型组合物 Download PDFInfo
- Publication number
- CN1188414A CN1188414A CN96194864A CN96194864A CN1188414A CN 1188414 A CN1188414 A CN 1188414A CN 96194864 A CN96194864 A CN 96194864A CN 96194864 A CN96194864 A CN 96194864A CN 1188414 A CN1188414 A CN 1188414A
- Authority
- CN
- China
- Prior art keywords
- compositions
- deslorelin
- disease
- lecithin
- tristearin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Steroid Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
狗 | 植入 | 观察(1个月后) |
BA1/6 | 1996年5月 | 没有治疗后的动情期 |
BA2/6 | 1996年5月 | 没有治疗后的动情期 |
BA3/6 | 1996年5月 | 没有治疗后的动情期 |
PW1/6 | 1996年5月 | 中等发情表现孕酮低下 |
PW4/12 | 1996年5月 | 治疗后孕酮降低 |
狗 | 植入 | 观察(0.5-1个月后) |
BA1/61 | 1996年6月 | 无发情 |
PW1/12 | 1996年5月 | 无发情 |
狗 | 植入 | 观察(2-5个月后) |
BB1/6 | 1996年1月 | 有发情表现,然后无活动 |
BB2/6 | 1996年2月 | 有发情表现,然后无活动 |
BB3/6 | 1996年2月 | 有发情表现,然后无活动 |
BB4/6 | 1996年3月 | 有发情表现,然后无活动 |
BB1/31 | 1996年4月 | 有发情表现,然后无活动 |
BB1/61 | 1996年4月 | 持续发情 |
狗编号 | 植入部位的组织学 | 恢复生殖(12个月后) |
狗46 | 未检测到细胞变化 | 是 |
狗79 | 未检测到细胞变化 | 是 |
狗40 | 未取组织 | 是 |
狗47 | 未取组织 | 是 |
Claims (12)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPN3667 | 1995-06-20 | ||
AUPN3667A AUPN366795A0 (en) | 1995-06-20 | 1995-06-20 | Formulation for preventing reproductive function |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1188414A true CN1188414A (zh) | 1998-07-22 |
CN1145496C CN1145496C (zh) | 2004-04-14 |
Family
ID=3788008
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB961948647A Expired - Lifetime CN1145496C (zh) | 1995-06-20 | 1996-06-20 | 用于肽释放的新型组合物 |
Country Status (17)
Country | Link |
---|---|
US (2) | US5925619A (zh) |
EP (1) | EP0871467B1 (zh) |
JP (1) | JP4016133B2 (zh) |
CN (1) | CN1145496C (zh) |
AT (1) | ATE223726T1 (zh) |
AU (2) | AUPN366795A0 (zh) |
CA (1) | CA2225796C (zh) |
DE (2) | DE122008000004I2 (zh) |
DK (1) | DK0871467T3 (zh) |
ES (1) | ES2182983T3 (zh) |
FR (1) | FR08C0001I2 (zh) |
HK (1) | HK1014874A1 (zh) |
NL (1) | NL300330I2 (zh) |
NZ (1) | NZ309697A (zh) |
PT (1) | PT871467E (zh) |
SI (1) | SI0871467T1 (zh) |
WO (1) | WO1997000693A1 (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPN366795A0 (en) * | 1995-06-20 | 1995-07-13 | Peptide Technology Limited | Formulation for preventing reproductive function |
CN1216636C (zh) * | 1996-08-30 | 2005-08-31 | 派普泰克有限公司 | 肽缓释组合物 |
US8052982B2 (en) * | 1998-07-20 | 2011-11-08 | Peptech Animal Health Pty Limited | Bioimplant formulation comprising lecithin and stearin |
WO2000004897A1 (en) * | 1998-07-20 | 2000-02-03 | Peptech Limited | Bioimplant formulation |
US6211221B1 (en) * | 1999-04-05 | 2001-04-03 | Johnny W. Peterson | Dietary supplement containing histidine for alleviating dysmenorrhea, endometriosis, and pre-term labor |
DE60113142T2 (de) * | 2000-10-30 | 2006-07-06 | University Of Zurich | Verwendung von gnrh-analogue zur behandlung der harninkontinenz |
GB0221539D0 (en) * | 2002-09-17 | 2002-10-23 | Medical Res Council | Methods of treatment |
US20060003008A1 (en) * | 2003-12-30 | 2006-01-05 | Gibson John W | Polymeric devices for controlled release of active agents |
EP1835885A1 (en) * | 2004-12-23 | 2007-09-26 | Durect Corporation | Polymeric implants, preferably containing a mixture of peg and plg, for controlled release of a gnrh |
KR20100063716A (ko) * | 2007-09-11 | 2010-06-11 | 몬도바이오테크 래보래토리즈 아게 | 치료제로서 사용하기 위한 아스트레신 및 베타-엔도르핀 |
DE102008015104A1 (de) | 2008-03-19 | 2009-09-24 | Basf Coatings Ag | Beschichtungszusammensetzung, Verfahren zu ihrer Herstellung, ihre Verwendung und mit ihr beschichtete Substrate |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS563846B2 (zh) * | 1972-10-12 | 1981-01-27 | ||
US4218439A (en) * | 1977-07-14 | 1980-08-19 | The Salk Institute For Biological Studies | Peptide which inhibits gonadal function |
US4256737A (en) * | 1979-06-11 | 1981-03-17 | Syntex (U.S.A.) Inc. | Long acting depot injectable formulations for LH-RH analogues |
CA1257199A (en) * | 1986-05-20 | 1989-07-11 | Paul Y. Wang | Preparation containing bioactive macromolecular substance for multi-months release in vivo |
DE3777721D1 (de) * | 1986-08-11 | 1992-04-30 | American Cyanamid Co | Zusammensetzungen zur parenteralen verabreichung und deren verwendung. |
US4897268A (en) * | 1987-08-03 | 1990-01-30 | Southern Research Institute | Drug delivery system and method of making the same |
US5538739A (en) * | 1989-07-07 | 1996-07-23 | Sandoz Ltd. | Sustained release formulations of water soluble peptides |
US5211952A (en) * | 1991-04-12 | 1993-05-18 | University Of Southern California | Contraceptive methods and formulations for use therein |
WO1993015722A1 (en) * | 1992-02-07 | 1993-08-19 | Syntex (Usa) Inc. | Controlled delivery of pharmaceuticals from preformed porous microparticles |
AUPN366795A0 (en) * | 1995-06-20 | 1995-07-13 | Peptide Technology Limited | Formulation for preventing reproductive function |
-
1995
- 1995-06-20 AU AUPN3667A patent/AUPN366795A0/en not_active Abandoned
-
1996
- 1996-06-20 US US08/981,285 patent/US5925619A/en not_active Expired - Lifetime
- 1996-06-20 AU AU59927/96A patent/AU701837B2/en not_active Expired
- 1996-06-20 CA CA2225796A patent/CA2225796C/en not_active Expired - Lifetime
- 1996-06-20 DK DK96917292T patent/DK0871467T3/da active
- 1996-06-20 JP JP50345797A patent/JP4016133B2/ja not_active Expired - Lifetime
- 1996-06-20 CN CNB961948647A patent/CN1145496C/zh not_active Expired - Lifetime
- 1996-06-20 ES ES96917292T patent/ES2182983T3/es not_active Expired - Lifetime
- 1996-06-20 AT AT96917292T patent/ATE223726T1/de active
- 1996-06-20 NZ NZ309697A patent/NZ309697A/xx not_active IP Right Cessation
- 1996-06-20 EP EP96917292A patent/EP0871467B1/en not_active Expired - Lifetime
- 1996-06-20 WO PCT/AU1996/000370 patent/WO1997000693A1/en active IP Right Grant
- 1996-06-20 PT PT96917292T patent/PT871467E/pt unknown
- 1996-06-20 DE DE122008000004C patent/DE122008000004I2/de active Active
- 1996-06-20 DE DE69623652T patent/DE69623652T2/de not_active Expired - Lifetime
- 1996-06-20 SI SI9630524T patent/SI0871467T1/xx unknown
-
1999
- 1999-01-08 HK HK99100086A patent/HK1014874A1/xx not_active IP Right Cessation
- 1999-02-17 US US09/251,411 patent/US6211152B1/en not_active Expired - Lifetime
-
2008
- 2008-01-08 NL NL300330C patent/NL300330I2/nl unknown
- 2008-01-10 FR FR08C0001C patent/FR08C0001I2/fr active Active
Also Published As
Publication number | Publication date |
---|---|
JP2001521482A (ja) | 2001-11-06 |
DE69623652T2 (de) | 2003-05-28 |
EP0871467A4 (en) | 2000-07-05 |
WO1997000693A1 (en) | 1997-01-09 |
DE122008000004I2 (de) | 2009-08-06 |
CN1145496C (zh) | 2004-04-14 |
NL300330I2 (nl) | 2008-04-01 |
US6211152B1 (en) | 2001-04-03 |
FR08C0001I2 (zh) | 2009-11-20 |
EP0871467A1 (en) | 1998-10-21 |
EP0871467B1 (en) | 2002-09-11 |
NZ309697A (en) | 1999-11-29 |
AUPN366795A0 (en) | 1995-07-13 |
JP4016133B2 (ja) | 2007-12-05 |
US5925619A (en) | 1999-07-20 |
CA2225796A1 (en) | 1997-01-09 |
AU701837B2 (en) | 1999-02-04 |
DE122008000004I1 (de) | 2008-04-17 |
AU5992796A (en) | 1997-01-22 |
NL300330I1 (nl) | 2008-03-03 |
ATE223726T1 (de) | 2002-09-15 |
DK0871467T3 (da) | 2002-12-23 |
FR08C0001I1 (zh) | 2008-03-21 |
CA2225796C (en) | 2011-09-20 |
DE69623652D1 (de) | 2002-10-17 |
SI0871467T1 (en) | 2003-08-31 |
ES2182983T3 (es) | 2003-03-16 |
HK1014874A1 (en) | 1999-10-08 |
PT871467E (pt) | 2002-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6337318B1 (en) | Sustained GnRH peptide-release formulation | |
Mylonas et al. | Preparation and evaluation of polyanhydride microspheres containing gonadotropin-releasing hormone (GnRH), for inducing ovulation and spermiation in fish | |
JP3313113B2 (ja) | 雌馬の排卵制御用生体適合性インプラント | |
US20050276854A1 (en) | Bioimplant formulation | |
MXPA02005911A (es) | Implante farmaceutico que contiene componentes de liberacion prolongada y de liberacion sostenida y metodo para su administracion. | |
EP0462959A1 (en) | Coated veterinary implants. | |
CN1145496C (zh) | 用于肽释放的新型组合物 | |
US5342622A (en) | Subdermal biocompatible implants | |
US20110142901A1 (en) | Sustained release composition | |
US20050118271A1 (en) | Polytartrate composition | |
Crim | Methods for acute and chronic hormone administration in fish | |
AU713413B2 (en) | Sustained peptide-release formulation | |
AU1843899A (en) | Novel formulation for peptide release | |
Peacock et al. | Pharmacokinetics and pharmacodynamics of a parenteral testosterone microsphere formulation in the male rat: Demonstration of dose dependence and controlled release | |
AU755443C (en) | Bioimplant formulation | |
AU2005249143A1 (en) | Sustained release composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CI01 | Publication of corrected invention patent application |
Correction item: Applicant Correct: Peptech Ltd. False: Pipetide Technology Ltd. Number: 29 Page: 85 Volume: 14 |
|
ERR | Gazette correction |
Free format text: CORRECT: APPLICANT; FROM: PEPTIDE TECHNOLOGY LTD. TO: PEPTECH CO., LTD. |
|
CI01 | Publication of corrected invention patent application |
Correction item: Applicant Correct: Peptech Ltd. False: Pipetide Technology Ltd. Number: 29 Volume: 14 |
|
ERR | Gazette correction |
Free format text: CORRECT: APPLICANT; FROM: PEPTIDE TECHNOLOGY LTD. TO: PIPTEC CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1014874 Country of ref document: HK |
|
C41 | Transfer of patent application or patent right or utility model | ||
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: New South Wales, Australia Patentee after: Alana Medical Ltd. Address before: New South Wales, Australia Patentee before: Peptech Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20090123 Address after: New South Wales, Australia Patentee after: Tektronix pypo animal health Co.,Ltd. Address before: New South Wales, Australia Patentee before: Alana Medical Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: PIPETEC ANIMALS HEALTH CO., LTD. Free format text: FORMER OWNER: ARANA MEDICAL CO., LTD. Effective date: 20090123 |
|
C56 | Change in the name or address of the patentee |
Owner name: ARANA MEDICAL CO., LTD. Free format text: FORMER NAME: PIPETEC CO., LTD. |
|
ASS | Succession or assignment of patent right |
Owner name: VIC (AUSTRALIA) LTD. Free format text: FORMER OWNER: PEPTECH ANIMAL HEALTH PTY. LIMITED Effective date: 20121120 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20121120 Address after: New South Wales Australia Patentee after: Vic (Australia) Ltd. Address before: New South Wales, Australia Patentee before: Tektronix pypo animal health Co.,Ltd. |
|
CX01 | Expiry of patent term |
Granted publication date: 20040414 |
|
EXPY | Termination of patent right or utility model |